Edition:
India

Vitrolife AB (VITR.ST)

VITR.ST on Stockholm Stock Exchange

674.50SEK
17 Jan 2018
Change (% chg)

1.00kr (+0.15%)
Prev Close
673.50kr
Open
669.00kr
Day's High
675.00kr
Day's Low
661.00kr
Volume
10,977
Avg. Vol
26,414
52-wk High
717.00kr
52-wk Low
388.00kr

Chart for

About

Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a... (more)

Overall

Beta: 0.58
Market Cap(Mil.): kr14,480.65
Shares Outstanding(Mil.): 21.71
Dividend: 2.60
Yield (%): 0.39

Financials

BRIEF-Vitrolife buys licensing rights for embryo transfer technology

* VITROLIFE ACQUIRES LICENSING RIGHTS TO TECHNOLOGY FOR EMBRYO TRANSFER

11 Jan 2018

BRIEF-William Demant fund raises stake in Vitrolife to 21.6 pct

* William Demants Og Hustru Ida Emilies Fond​ (Oticon fund) raises stake in Vitrolife AB to 21.6 percent

10 Nov 2017

BRIEF-Vitrolife Q3 core profit rises, like-for-like sales grow 20 pct​

* Q3 ‍sales amounted to SEK 246 (210) million, corresponding to an increase of 17 percent in SEK​

02 Nov 2017

Earnings vs. Estimates